Abstract
Lung cancer is the most common cause of cancer deaths worldwide. Although tobacco smoking is considered to be the main risk factor and the most well-established risk factor for lung cancer, a number of patients who do not smoke have developed this disease. This number varies between 15 % to over one-half of lung cancer cases, and the deaths from lung cancer in non-smokers are increasing every year. There are many other agents that are thought to be etiological, including diesel exhaust exposure, metals, radiation, radon, hormonal factors, cooking oil, air pollution and infectious diseases, such as human papillomavirus (HPV). Studies in various parts of the world have detected HPV DNA at different rates in lung tumors. However, the role of HPV in lung cancer is still unclear. Thus, in this review, we investigated some molecular mechanisms of HPV protein activity in host cells, the entry of HPV into lung tissue and the possible route used by the virus to reach the lung cells.
Similar content being viewed by others
References
Aguayo F, Castillo A, Koriyama C, Higashi M, Itoh T, Capetillo M, Shuyama K, Corvalan A, Eizuru Y, Akiba S (2007) Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 97:85–91
Aguayo F, Anwar M, Koriyama C, Castillo A, Sun Q, Morewaya J, Eizuru Y, Akiba S (2010) Human papillomavirus-16 presence and physical status in lung carcinomas from Asia. Infect Agent Cancer 5:20
Aguayo F, Khan N, Koriyama C, González C, Ampuero S, Padilla O, Solís L, Eizuru Y, Corvalán A, Akiba S (2011) Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile. Infect Agent Cancer 6:7
Amabile JC, Leuraud K, Vacquier B, Alain A, Dominique L (2009) Multifactorial study of the risk of lung cancer among French uranium miners: radon, smoking and silicosis. Health Phys 97(6):613–621
Baba M, Castillo A, Koriyama C, Yanagi M, Matsumoto H, Natsugoe S, Shuyama KY, Khan N, Higashi M, Itoh T et al (2010) Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep 23(4):1085–1092
Bachman KE, James GH, Paul GC, Adrian M, Joseph FC, Webster KC, Stephen BB, Jeremy RG (1999) Methylation-associated silencing of the tissue inhibitor of Metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers. Cancer Res 59:798–802
Bah PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer—a systematic review. JAMA 307(22):2418–2429
Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31(6):1441–1444
Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, De Villers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401(1):70–79
Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM (2005) Could human papillomaviruses be spread through blood? J Clin Microbiol 43(11):5428–5434
Bodily J, Laimins LA (2011) Persistence of human papillomavirus infection: key to malignant progression. Trends Microbiol 19(1):33–39
Bohlmeyer T, Le TN, Shroyer L, Markham N, Shtoyer KR (1998) Detection of Human Papillomavirus in Squamous Cell Carcinomas of the lung by Polymerase Chain Reaction. Am J Respir Cell Mol Biol 18:265–269
Boyer SN, Wazer DE, Band V (1996) E7 protein of human papillomavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620–4624
Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL (1996) Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol 149(6):1941
Branica BV, Smojer-Jezek S, Juros Z, Grgic S, Srpak N, Mitrecic D, Gajovic S (2010) Detection of human papillomaviruses type 16, 18 and 33 in bronchial aspirates of lung carcinoma patients by polymerase chain reaction: a study of 84 cases in croatia. Coll Antropol 34(1):159–162
Brat DJ, Bellail AC, Van Meir EG (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 7(2):122–133
Buonomo T, Carraresi Laura, Rossini Mara, Martinelli Rosanna (2011) Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins. J Transl Med 9(2):1–11
Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1–17
Burke L, Mohammed AK, Andrew NF et al (1998) Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Cancer Res 58:2533–2536
Butler D, Collins C, Mabruk M, Walsh CB, Leader MB, Kay EW (2000) Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features. J Pathol 192:502–510
Carpagnano GE, Koutelou A, Natalicchio MI, Martinelli D, Ruggieri C, Di Taranto A, Antonetti R, Carpagnano F, Foschino-Barbaro MP (2011) HPV in exhaled breath condensate of lung cancer patients. Br J Cancer 105:1183–1190
Castillo A, Aguayo F, Koriyama C, Shuyama K, Akiba S, Herrera-Goepfert R, Carrascal E, Klinge G, Sánchez J, Eizuru Y (2006) Human papillomavirus in lung carcinomas among three Latin American countries. Oncol Rep 15:883–888
Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YHW (2006) DDX3, a dead box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res 66(13):6579–6588
Chen ACH, Keleher A, Kedda MA, Spurdle AB, McMillan NA, Antonsson A (2009) Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol 81(10):1792–1796
Chen ZM, Peto R, Iona A et al (2015) Emerging tobacco-related cancer risks in China: a nationwide, prospective study of 0.5 million adults. Cancer 121(S17):3097–3106
Cheng YW, Chiou HL, Sheu GT et al (2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61(7):2799–2803
Cheng YW, Wu MF, Wang J, Yeh KT, Goan YG, Chiou HL, Chen CY, Lee H (2007) Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 67:10686–10693
Cheng YW, Lee H, Shiau MY, Wu TC, Huang TT, Chang YH (2008a) Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer. Clin Cancer Res 14(15):4705–4712
Cheng YW, Wu TC, Chen CY, Chou MC, Ko JL, Lee H (2008b) Human Telomerase Reverse Transcriptase Activated by E6 Oncoprotein Is Required for Human Papillomavirus-16/18-Infected Lung Tumorigenesis. Clin Cancer Res 14(22):7175–7179
Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H (2003) The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 97(6):1558–1563
Ciotti M, Giuliani L, Ambrogi V, Ronci C, Benedetto A, Mineo TC, Syrjänem K, Favalii C (2006) Detection and expression of human papillomavirus oncogenes in non-small cell lung câncer. Oncol Rep 16:183–189
Coissard CJ, Besson G, Polete MC, Monteau M, Birembaut PL, Clavel CE (2005) Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 18:1606–1609
Dong SM, Pai SI, Rha SH, Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA et al (2002) Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomark Prev 11(1):3–6
Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30(Suppl 5):F55–F70
Dyson N, Guida P, Munger K, Harlow E (1992) Homologous sequences in adenovirus E1 A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66(1):6893–6902
Elferink CJ, Ge NL, Levine A (2001) Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol Pharmacol 59(4):664–673
Finzer P, Kuntzen C, Soto U, zur Hausen H, Rösl F (2001) Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 20(35):4768–4776
Freije JMP, Milagros B, Alberto MP, Luis MS, Xose SP, Carlos LO (2003) Matrix metalloproteinases and tumor progression. Adv Med Biol 532:91–107
Frolov MV, Dyson NJ (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117(11):2173–2181
Fuller-Pace FV (2013) DEAD box RNA helicase functions in cancer. RNA Biol 10(1):121–132
Gabrielson E (2006) Worldwide trends in lung cancer pathology. Respirology 11(5):533–538
Ge NL, Elferink CJ (1998) A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. J Biol Chem 273(35):22708–22713
Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D’Antonio D, Syrjanen K, Favalli C, Ciotti M (2007) Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 57(3):273–281
Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74(2):111–122
Goto A, Li CP, Ota S et al (2011) Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J Med Virol 83(8):1383–1390
Hadju SI (2006) A note from history: The link between koilocytes and human papillomaviruses. Ann Clin Lab Sci 36(4):485–487
Hensing T, Chawla A, Batra R, Salgia R (2014) A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. In: Systems Analysis of Human Multigene Disorders. Springer, New York. pp 85–117
Hirayasu T, Iwamasa T, Kamada Y, Koyanagi Y, Usuda H, Genka K (1996) Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 49(10):810–817
Hiroshima K, Toyozaki T, Iyoda A, Ohwada H, Kado S, Shirasawa H, Fujisawa T (1999) Ultrastructural study of intranuclear inclusion bodies of pulmonary adenocarcinoma. Ultrastruct Pathol 23(6):383–389
Ho CM, Yang SS, Chien TY, Huang SH, Jeng CJ, Chang SF (2005) Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients. Gynecol Oncol 99(3):615–621
Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, Crawford J, Neidhart JA (1995) Measurement of quality of life in patients with lung cancer in multicenter Trials of New Therapies. Cancer 73(8):2087–2098
Hsu NY, Cheng YW, Chan IP, Ho HC, Chen CY, Hsu CP, Lin MH, Chou MC (2009) Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep 21(1):81–87
Huang HK, Joazeiro CAP, Bonfoco E, Kamada S, Leverson JD, Hunter T (2000) The inhibitor of apoptosis, ciap2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 275(35):26661–26664
Huang Y, Huang MN, Li N, Li XG, Wu LY (2008) Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer. Int J Gynecol Cancer 18:755–760
Huibregtse JM, Scheffner M, Howley PM (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 13(2):775–784
Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R, Murthy NS, Husain SA, Das BC (2005) Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128(6):3999–4007
James MA, Lee JH, Klingelhutz AJ (2006) HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. Int J Cancer 119:1878–1885
Joh J, Jenson AB, Moore GD, Rezazedeh A, Slone SP, Ghim SJ, Kloecker GH (2010) Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 89(3):222–226
Kashima H, Mounts P, Leventhal B, Hruban RH (1993) Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 102:580–583
Kato T, Loriyama C, Khan N, Samukawa T, Yanagi M, Hamada T, Yokomakura N, Otsuka T, Inoue H, Sato M, Natsugoe S, Akiba S (2012) EGFR mutations and human papillomavirus in lung cancer. Lung Cancer 78:144–147
Kinoshita I, Dosaka-Akita H, Shindoh M, Fujino M, Akie K, Kato M, Fujinaga K, Kawakami Y (1995) Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 71(2):344
Koshiol J, Rotunno M, Gillison ML et al (2011) Assessment of human papillomavirus in lung tumor tissue. J Nati Cancer Inst 103(6):501–507
Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D (2001) Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21WAF1/Cip1 gene by the p53 tumor suppressor protein. J Biol Chem 276(31):29116–29125
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701–4714
Kulski JK, Demeter T, Mutavdzic S, Sterrett GF, Mitchell KM, Pixley EC (1990) Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization. Am J Clin Pathol 94(5):566–570
Kyo S, Takakura M, Fujiwara T et al (2008) Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99:1528–1538
Lai MC, Chang WC, Shieh SH, Tarn WY (2010) DDX3 regulates cell growth through translational Control of cyclin E1. Mol Cell Biol 30(22):5444–5453
Li G, He L, Zhang E, Shi J, Zhang Q, Le AD, Zhou K, Tang X (2011) Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1a and VEGF expression in non-small cell lung cancer cells. Cancer Lett 311:160–170
Liu VW, Tsang P, Yip A, Ng TY, Wong LC, Ngan HY (2001) Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol 82(2):269–272
Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, Tomaić V, Kelley ML, Baker CC, Huibregtse J, Schlegel R (2005) The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem 280(11):10807–10816
Major T, Szarka K, Sziklai I, Gergely L, Czeglédy J (2005) The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 58(1):51–55
Matakidou A, Eisen T, Houlston RS (2005) Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 93:825–833
Mehra R, Egleston B, Yang D, Scott W, Borghaei H, Ragin C (2013) A pilot study of the association and prevalence of the human papillomavirus (HPV) in non-small cell lung cancer (NSCLC). Cancer Res 73:4785
Miyagi J, Tsuhako K, Kinjo T, Iwamasa T, Hirayasu T (2000) Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 53(9):676–684
Mork J, Lie KL, Glattre E, Clark S, Phill D, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Wang Z, Youngman L, Lehtinem M, Dilner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125–1131
Nadji SA, Azad TM, Mahmoodi M, Yahyapour Y, Naghshvar F, Torabizadeh J, Ziaee AA, Nategh R (2007) Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett 248:41–46
Nuorva K, Soini Y, Kamel D, Pöllänen R, Bloigu R, Vähäkangas K, Pääkkö P (1995) p53 protein accumulation and the presence of human papillomavirus dna in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int J Cancer 64(6):424–429
Pao CC, Lin SS, Lin CY, Maa JS, Lai CH, Hsieh TT (1991) Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol 95(4):540–546
Pao CC, Hor JJ, Yang FP, Lin CY, Tseng CJ (1997) Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J clin oncol 15(3):1008–1012
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
Peña N, Carrillo D, Muñoz JP, Chnaiderman J, Urzúa U, León O, Tornesello ML, Corvalán AH, Soto-Rifo R, Aguayo F (2015) Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk e6/e7 for oxidative dna damage in lung cells. PLoS One 10(4):e0123029
Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP (2008) Transplacental transmission of human papillomavirus. Virol J 5:106
Rubel L, Reynolds RE (1979) Cytologic description of squamous cell papilloma of the respiratory tract. Acta Cytol 23(3):227–231
Samet JM (1991) Health benefits of smoking cessation. Clin Chest Med 12:669–679
Sarchianaki E, Derdas SP, Ntaoukakis M et al (2014) Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumor Biol 35:3203–3209
Schamberger AC, Staab-Weijnitz CA, Mise-Racek N, Eickelberg O (2015) Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface. Scientific reports, 5
Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer Cell 2(2):103–112
Shiau MY, Fan LC, Yang SC, Tsao CH, Lee H, Cheng YW, Lai LC, Chang YH (2013) Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas. PLoS One 8(1):e54423
Shih CM, Lee YL, Chiou HL, Hsua WF, Chen WE, Chou MC, Lin LY (2005) The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 50:291–297
Silverman DT, Samanic CM, Lubin JH et al (2012) The Diesel Exhaust in Miners Study: A Nested Case-Control Study of Lung Cancer and Diesel Exhaust. J Natl Cancer Inst 104:1–14
Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108:766–772
Sozzi G, Sozi G, Pastorino U et al (1998) Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58:5032–5037
Steenbergen RD, de Wild J, Wilting SM et al (2005) HPV-mediated transformation of the anogenital tract. J Clin Virol 32:S25–S33
Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers-a different disease. Nature 7:778–790
Sung WW, Lee H (2013) The role of interleukin-10 in the progression of human papillomavirus-associated lung carcinoma. OncoImmunology 2(9):e25854
Sung WW, Wang YC, Lin PL, Cheng YW, Chen CY, Wu TC, Lee H (2013) IL-10 promotes tumor aggressiveness via upregulation of cip2a transcription in lung adenocarcinoma. Clin Cancer Res 19(15):4092–4103
Syrjänen KJ (1979) condylomatous changes in neoplastic bronchial epithelium. Respiration 38:299–304
Syrjänen KJ (1980) Epithelial lesions suggestive of a condylomatous origin found closely associated with invasive bronchial squamous cell carcinomas. Respiration 40(3):150–160
Syrjänen KJ (2002) HPV infections and lung cancer. J Clin Pathol 55(12):885–891
Syrjänen S (2005) Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32:59–66
Syrjänen K (2012) Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res 32(8):3235–3250
Syrjänen K, Syrjänen S, Kellokoski J, Kärjä J, Mäntyjärvi R (1989) Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization. Lung 167(1):33–42
Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, Smith DI (2000) Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 60:5916–5921
Torok S, Hegedus B, Laszlo V, Hoda MA, Ghanim B, Berger W, Klepetko W, Dome B, Ostoros G (2011) Lung cancer in never smokers. Future Oncol 7(10):1195–1211
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108
Tsai HJ, Peng YW, Lin LY, Chou MC, Lee H, Chiou HL (2005) An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions. Cancer Detect Prev 29(6):537–543
Tsuhako K, Nakazato I, Hirayasu T, Sunakawa H, Iwamasa T (1998) Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 51(10):741–749
Tung MC, Wu HH, Cheng YW, Wang L, Chen CY, Yeh SD, Wu TC, Lee H (2013) Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer. Cancer 119(18):3367–3376
Turek LP, Smith EM (1996) The genetic program of genital human papillomaviruses in infection and cancer. Obstet Gynecol Clin 23(4):735–758
Wang T, Zeng X, Li W, Zhu H, Wang G, Liu X, Lv Y, Wu J, Zhuang X, Zhang J et al (2014) Detection and analysis of human papillomavirus (HPV) DNA in breast cancer patients by an effective method of HPV capture. PLoS One 9(3):e90343
Whitlock JP Jr (1999) Induction of cytochrome P4501A1. Ann Rev Pharmacol Toxicol 39:103–125
WHO (2012) Lung cancer estimated incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=lung
Wilson EB, Brooks DG (2011) The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol 350:39–65
Wu EW, Clemens KE, Heck DV, Munger K (1993) The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol 67(4):2402–2407
Wu MF, Cheng YW, Lai JC, Hsu MC, Chen JT, Liu WS, Chiou MC, Chen CY, Lee H (2005) Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer 113:440–445
Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y (2006) Association of high-risk HPV types and viral load with cervical câncer in China. J Clin Virol 35:264–269
Wu M, Min C, Wang X, Yu Z, Kirsch KH, Trackman PC, Sonenshein GE (2007) Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res 67(13):6278–6285
Wu HH, Wu JY, Cheng YW, Chen CY, Lee MC, Goan YG, Lee H (2010) cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18–infected lung cancer. Clin Cancer Res 16(21):5200–5210
Wu DW, Tsai LH, Chen PM et al (2011) Reduced p21WAF1/CIP1 via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer. Clin Cancer Res 17:1895–1905
Wu DW, Tsai LH, Chen PM et al (2012) Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer. Am J Pathol 181(5):1796–1806
Xu Y, Cheng B, Pan H, Wu A, Zhang L (2009) The relationship between the status of human papillomavirus 16/18 infection and the expression of Bcl-2 and bax in squamous cell carcinomas of the lung. Chin J Lung 12(8):849–852
Xue X, Zhihua Y, Lu Y et al (2013) The joint effect of hOGG1, APE1, and ADPRT polymorphisms and cooking oil fumes on the risk of lung adenocarcinoma in chinese non-smoking females. PLoS One 8(8):e71157
Yanagawa N, Wang A, Kohler D, Santos GC, Sykes J, Xu J, Pintilie M, Tsao MS (2013) Human papilloma virus genome is rare in North American non-small cell lung carcinoma patients. Lung Cancer 79(3):215–220
Yang P (2011) Lung cancer in never smokers. Semin Respir Crit Care Med 32(1):10
Yano T, Miura N, Takenaka T et al (2008) Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic feature and survival. Cancer 113:1012–1018
Yohena T, Yoshino I, Takenaka T, Kameyama T, Ohba T, Kuniyoshi Y, Maehara Y (2009) Upregulation of hypoxia-inducible factor-1α mRNA and its clinical significance in non-small cell lung cancer. J Thorac Oncol 4(3):284–290
Yu Y, Yang A, Hu S, Yan H (2009) Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol Rep 21(6):1627–1632
Yu YH, Liao CC, Hsu WH et al (2011) Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol 6(1):32–37
Yuan A, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT, Yang PC (2000) Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 89(6):475–483
Zhang E, Feng X, Liu F, Zhang P, Liang J, Tang X (2014) Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS One 9(7):e103440
Zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92(9):690–698
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that he/she has no conflict of interest. Author B declares that he/she has no conflict of interest.
Human participants and/or animals
This article does not contain any studies with human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
de Freitas, A.C., Gurgel, A.P., de Lima, E.G. et al. Human papillomavirus and lung cancinogenesis: an overview. J Cancer Res Clin Oncol 142, 2415–2427 (2016). https://doi.org/10.1007/s00432-016-2197-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-016-2197-1